Benzodiazepines, methadone and buprenorphine: interactions and clinical management
Saved in:
Lintzeris, N., Nielsen, S., Benzodiazepines, methadone and buprenorphine: interactions and clinical management. American Journal on Addictions, Vol. 19, no. 1 (2010), p. 59-72.
Ref.
185671
Location:
SIIS R.1264 Archivo
Palabras clave:
Ansiedad, Buprenorfina, Diagnóstico dual, Drogodependencias, Enfermedades mentales, Estudio epidemiológico, Fármacos, Interacción, Metadona, Mortalidad, Opiáceos, Programas de mantenimiento, Tratamiento, Australia
Ansiedad, Buprenorfina, Diagnóstico dual, Drogodependencias, Enfermedades mentales, Estudio epidemiológico, Fármacos, Interacción, Metadona, Mortalidad, Opiáceos, Programas de mantenimiento, Tratamiento, Australia
Similar Items: Benzodiazepines, methadone and buprenorphine: interactions and clinical management
- Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review
- Lack of clinically significant drug interactions between nevirapine and buprenorphine
- Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) Didanosine, Lamivudine, and Tenofovir
- DRUG INTERACTION- METHADONE DRUG INTERACTIONS. EN: DRUG MISUSE AND DEPENDENCE- GUIDELINES ON CLINICAL MANAGEMENT.
- PHARMACODYNAMICS OF DIAZEPAM CO ADMINISTERED WITH METHADONE OR BUPRENORPHINE UNDER HIGH DOSE CONDITIONS IN OPIOID DEPENDENT PATIENTS
- METHADONE DRUG INTERACTIONS